Commonwealth Bank of Australia’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-612,348
Closed -$23.1M 859
2018
Q1
$23.1M Buy
612,348
+716
+0.1% +$25.3K 0.25% 74
2017
Q4
$19.8M Sell
611,632
-191,100
-24% -$6.07M 0.19% 97
2017
Q3
$24M Buy
802,732
+83,220
+12% +$2.47M 0.23% 85
2017
Q2
$21.1M Buy
719,512
+670,164
+1,358% +$18.3M 0.21% 87
2017
Q1
$1.25M Buy
+49,348
New +$1.27M 0.01% 457
2014
Q2
Sell
-73,600
Closed -$1.57M 1010
2014
Q1
$1.57M Sell
73,600
-182,544
-71% -$4.11M 0.01% 720
2013
Q4
$6.06M Sell
256,144
-8,004
-3% -$173K 0.04% 374
2013
Q3
$5.29M Buy
264,148
+44,756
+20% +$849K 0.04% 388
2013
Q2
$3.79M Buy
+219,392
New +$3.64M 0.03% 439

Other funds holding TECH

Commonwealth Bank of Australia's TECH Position: Q2 2018 in Review

Commonwealth Bank of Australia sold out of Bio-Techne (TECH) in Q2 2018, closing a stake of 612,348 shares — an estimated $23.1M sold.

Commonwealth Bank of Australia first reported a position in TECH in Q2 2013 and held it in 9 quarters. The position peaked at $24M in Q3 2017. 342 funds tracked by Wall St. Rank hold TECH as of Q2 2018.

  • Commonwealth Bank of Australia reported no remaining Bio-Techne position as of Q2 2018 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 612,348 Bio-Techne shares in Q2 2018, an estimated $23.1M.
  • Commonwealth Bank of Australia first reported a position in Bio-Techne in Q2 2013 and held it in 9 quarters.
  • Commonwealth Bank of Australia's Bio-Techne position peaked at $24M in Q3 2017.
  • 342 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2018.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2018, filed 13 Aug 2018.